Navigation Links
Perceptum Group Announces New Situational Leadership V Series
Date:10/2/2009

Company expands its management development service offering with the addition of Situational Leadership V™ series to its portfolio.

San Francisco, Calif. (PRWEB) October 2, 2009 -- Perceptum Group, LLC announced today the introduction of its new Situational Leadership V (SLV) series specifically for biotech and specialty pharma companies. The new series includes Situational Leadership V™, Situational Self Leadership and Advanced Situational Leadership V™.

In Situational Leadership V the Perceptum Group expands upon Hersey and Blanchard's models to now include five developmental levels and leadership styles. Participants are taught to use emotional intelligence concepts, conflict management techniques, and effective communication strategies to facilitate application of situational leadership. Situational Self Leadership teaches life sciences sales representatives, whose time is primarily spent in the field by themselves, on how to acquire the ability to be "self leaders." Advanced Situational Leadership V provides sales managers practical leadership tools they can use to accelerate a sales representative's development from enthusiastic beginner to peak performer.

Perceptum customizes each SLV program to the specific products, market space and sales culture of its biotech and specialty pharma clients. "Delivering programs that are relevant to our life sciences clients by utilizing client-specific, field-based situations greatly enhances the value and effectiveness in achieving desired short and long-term behaviors" said Don Wright, Perceptum's Vice President of Business Development. "The SLV series will provide life sciences companies a common leadership framework throughout their entire organization."

To learn more about Perceptum's Situational Leadership V, go to:

http://www.perceptumgroup.com/specialty-pharmaceutical/situational-leadership-v.php    

or

http://www.perceptumgroup.com/biotechnology/situational-leadership-v.php

About Perceptum Group

The Perceptum Group is the leading training, education and development company for the life sciences industry. Biotechnology, specialty pharmaceutical, and medical device companies seeking to expand and develop their markets rely on the Perceptum Group for sales and physician training as well as development of their sales management professionals. Perceptum catalyzes insights for a company's sales organization, builds their capabilities, mobilizes them to act and helps execute in the field to drive measurable results. The Perceptum Group is a privately held consulting firm headquartered in San Francisco, California providing services in the U.S., EU and Latin America. For more information please visit www.perceptumgroup.com or call 415.495.3331.

###

Read the full story at http://www.prweb.com/releases/2009/10/prweb2980874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Avicena Group to Present at Noble Financial Conference
2. Chrome Group to Seek Listing for Some of its Subsidiaries
3. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
4. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. ThirdBiotech Networking Group Launches
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
11. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):